Precise 3-D imaging of skin cancer tumours

November 15, 2017, Agency for Science, Technology and Research (A*STAR), Singapore

Scientists and clinicians from Singapore and Germany have successfully used multispectral optoacoustic tomography (MSOT) to achieve accurate, real-time 3-D imaging of non-melanoma skin cancer tumours. This imaging technique uses a combination of light pulses and ultrasound waves to form 3-D images that are precise in dimensions and depth.

This is a breakthrough in non-invasive skin imaging, as this technique allows for the imaging of tumours that are deep below the skin (up to 30mm below the skin surface) and provides high-resolution results with clear differentiation of the various tissues. Current imaging techniques can only image tumours no deeper than 3mm below the skin, and in some cases produce results that do not accurately show the tumour in contrast to other tissues such as fat.

The team that discovered this comprised of scientists from A*STAR's Singapore Bioimaging Consortium (SBIC) and the Technical University of Munich (TUM) in Germany, and clinicians from the National Skin Centre (NSC) and the Skin Research Institute of Singapore (SRIS) who ran the patient tests. The findings were published in Elsevier's Photoacoustics journal and were highlighted as a promising first-in-man clinical study during the recent 2017 World Molecular Imaging Congress.

Due to limitations in existing skin imaging tools, non-melanoma tumours cannot be imaged clearly pre-surgery, often resulting in either excess or incomplete removal of the cancerous tissue. Through the use of MSOT, the team found a way to overcome these limitations. This technique produces images by sending out of varying wavelengths that tissues absorb, expand, and emit which converge to form images. Since different tissues absorb different wavelengths of light, varying the wavelength will reveal which tissues are present. The high-resolution produced using MSOT allow clinicians and doctors to view the lesions' dimensions, depth, and the underlying vascular tissue. Such information is critical in identifying cancer and the level of aggression of a tumour.

One of the main techniques for treating skin cancer is Mohs micrographic surgery, which involves the removal of one layer of at a time, which is then studied under a microscope to ensure that there are no more cancer cells. Compared to this time-consuming procedure, the application of MSOT pre-surgery could enable much shorter surgical procedures due to the highly accurate identification of tumour size, depth and contrast versus surrounding tissues.

"This first-in-man study has successfully demonstrated that the use of MSOT can vastly improve the accuracy of the diagnosis and effectiveness of the treatment of non-melanoma skin cancer," said Prof Malini Olivo, Director of Biophotonics and Head of the Laboratory of Bio-Optical Imaging at SBIC, who led the study.

Prof Steven Thng, Executive Director of SRIS and Senior Consultant of NSC, who co-led the study, said: "The ability to image skin cancer in 3-D in-vivo will prove to be the disruptive technology for skin cancer management in future. This will change the paradigm of how skin cancer will be managed as dermatosurgeons will now be able to visualise the tumour before surgery and individualise surgery based on tumour characteristics and size. This will minimise relapse rates due to inadequate surgery, and reduce unnecessary scarring because of oversampling."

In Singapore, skin cancer is among the top 10 most common cancers in both men and women. The two most common types of skin in Singapore are basal cell carcinoma and squamous cell carcinoma, both non-melanoma cancers.

Explore further: Melanoma isn't the only serious skin cancer

Related Stories

Melanoma isn't the only serious skin cancer

July 27, 2017
(HealthDay)—A type of skin cancer called squamous cell carcinoma (SCC) is increasingly common in the United States, so people need to be alert for signs of the disease, an expert says.

The role of smartphones in skin checks for early detection of melanoma

September 7, 2017
QUT skin cancer researchers are seeking community volunteers to participate in a skin self-examination study. Performed regularly, self-examination can alert you to changes in your skin and may improve the early detection ...

PERFI feasible for in vivo imaging of nonmelanoma skin cancer

June 4, 2017
(HealthDay)—Polarization-enhanced reflectance and fluorescence imaging (PERFI) is feasible for in vivo intraoperative imaging of nonmelanoma skin cancer (NMSC), according to a study published online May 25 in Lasers in ...

Could a scan someday replace lymph node biopsy?

December 10, 2015
(HealthDay)—Scientists are testing a noninvasive alternative to lymph node biopsy for detecting early signs that melanoma skin cancer has spread.

Skin cancer model boost for prevention and treatment

January 18, 2017
Researchers at the University of Dundee have found that skin cancers in mice can closely mirror those found in humans, offering a model that could be used to help develop new drugs and find new ways of preventing the disease.

Photoacoustic and magnetic resonance imaging visualizes blood flow and oxygenation status in brain tumor tissue

July 20, 2016
Cancer diagnostics and therapy monitoring have moved into a new dimension through A*STAR research, which has developed a high-resolution and noninvasive approach to visualize brain tumors by combining photoacoustic with magnetic ...

Recommended for you

Researchers discover novel mechanism linking changes in mitochondria to cancer cell death

February 20, 2018
To stop the spread of cancer, cancer cells must die. Unfortunately, many types of cancer cells seem to use innate mechanisms that block cancer cell death, therefore allowing the cancer to metastasize. While seeking to further ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.